You are here: Industry Insights > Therapies

News List

BPSA releases guide to production of cell and gene therapies europeanpharmaceuticalreview
April 10, 2019
The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest whitepaper…
Amgen launches first biosimilar of best-selling Humira in Europe pharmatimes
October 19, 2018
Amgen has announced the launch of a proprietary biosimilar version of Abbvie's best-selling drug Humira (adalimumab) across all European markets, beginning 16 October.
Aquinnah Pharmaceuticals receives $3.4 million grant to advance ALS therapies pharmafile
June 22, 2018
Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to advance novel therapeutic drug candidates
Six new therapies backed for EU approval pharmatimes
March 27, 2018
Six medicines have taken a big step towards European approval having been recommended by the European Medicines Agency’s Committee for Medicinal Products for Human Use.
Seven therapies backed for EU approval pharmatimes
December 19, 2017
Seven therapies have been put forward for approval in the European Union, bringing closer new options for a range of conditions including Crohn’s disease, diabetes and cancer.

Previous page 1 2 Next page